Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymogen

Glu-Trp, EW dipeptide, Oglufanide, L-Glutamyl-L-tryptophan

Quick Stats
Studies 94
Trials 51
Score 2
1994 pubmed

[Radiation protective effect of low molecular weight thymus preparations].

Baraboĭ. V A VA; Ialkut. S I SI; Savtsova. Z D ZD; Zinchenko. V A VA; Zhukova. V M VM; Zaritskaia. M Iu MIu

Key Findings

  • Thymogen (and similar thymus extracts) showed measurable protection against radiation‑induced damage in animal models.
  • The protective effect covered three main radiation injury syndromes: hematopoietic (blood), gastrointestinal, and immunodepressive.
  • The paper discusses possible mechanisms, but does not provide detailed dosing or human trial data.

Practical Outcomes

  • For biohackers, thymogen might be considered as a potential radioprotective supplement, especially for those exposed to medical imaging or planning high‑altitude/space activities. However, the evidence is still pre‑clinical, dosing is unclear, and safety in healthy humans has not been established, so use should be cautious and preferably guided by further research.

Summary

The study found that low‑molecular‑weight thymus extracts such as thymogen can lessen the harmful effects of radiation on blood formation, the gut, and the immune system. The authors suggest that these extracts work by supporting the body’s natural repair pathways after radiation exposure.

Abstract

The antiradiation efficiency of low molecular thymic preparations (vilosen, thymogen) was determined. The therapeutic activity of thymic preparations is due to their influence on basic radiation injury syndromes (hemopoietic, gastrointestinal, immunodepressive). The protective mechanisms and perspectives of thymic preparations using in pathogenic therapy of radiation diseases are discussed.

Study Information

Provider

pubmed

Year

1994